Literature DB >> 10749154

Frontalis muscle flap advancement for correction of blepharoptosis.

S H Goldey1, H I Baylis, R A Goldberg, N Shorr.   

Abstract

PURPOSE: To describe a technique of frontalis muscle flap advancement to repair myogenic ptosis in lieu of a graft or suture material.
METHODS: Ten ptotic eyelids in eight patients were repaired using the frontalis flap technique. Patients were selected at random by two separate surgeons; all patients had eyelid excursion measured as poor (or less than 6 mm).
RESULTS: Nine of 10 ptotic eyelids were adequately corrected by the frontalis flap technique, with follow-up intervals ranging from 18 to 42 months. Adequate correction was defined as ptosis corrected within 1 mm of the fellow eyelid. Complications of frontalis advancement were few and primarily transient.
CONCLUSIONS: Frontalis flap advancement is a technically simple, safe, and effective technique for the repair of myogenic ptosis. The primary advantage of frontalis muscle flap advancement over a graft or suture material that it elevates the eyelid directly by moving the insertion of the frontalis muscle into the eyelid, rather than by graft or suture material.

Entities:  

Mesh:

Year:  2000        PMID: 10749154     DOI: 10.1097/00002341-200003000-00002

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  The inflammation influence on corneal surface after frontalis suspension surgery.

Authors:  Kang Li; Xin-Chun Zhang; Xian-Xian Cai; Ya-Dan Quan; Rong Lu
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

2.  Current techniques in surgical correction of congenital ptosis.

Authors:  Felicia D Allard; Vikram D Durairaj
Journal:  Middle East Afr J Ophthalmol       Date:  2010-04

3.  The Function-Preserving Frontalis Orbicularis Oculi Muscle Flap for the Correction of Severe Blepharoptosis With Poor Levator Function.

Authors:  Shu-Hung Huang; Chia-Chen Lee; Hsin-Ti Lai; Hidenobu Takahashi; Yu-Chi Wang; Chung-Sheng Lai
Journal:  Aesthet Surg J       Date:  2021-05-18       Impact factor: 4.283

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.